Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Naïve adults
about
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-Naïve adults
description
scientific article published on 03 June 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Immunogenicity and safety of a ...... ial in flavivirus-Naïve adults
@en
Immunogenicity and safety of a ...... ial in flavivirus-Naïve adults
@nl
type
label
Immunogenicity and safety of a ...... ial in flavivirus-Naïve adults
@en
Immunogenicity and safety of a ...... ial in flavivirus-Naïve adults
@nl
prefLabel
Immunogenicity and safety of a ...... ial in flavivirus-Naïve adults
@en
Immunogenicity and safety of a ...... ial in flavivirus-Naïve adults
@nl
P2093
P1476
Immunogenicity and safety of a ...... ial in flavivirus-naïve adults
@en
P2093
Amy Falk Russell
Andrew Bett
Beth-Ann Coller
David Radley
Donna Hyatt
Janakan Krishnarajah
Jason Lickliter
Jason Martin
Michele Sausser
Susan B Manoff
P304
P356
10.1080/21645515.2018.1546523
P577
2019-06-03T00:00:00Z